It’s not all bad in the fight against the coronavirus. Let’s leave you with five reasons to be cheerful, in the form of positive developments vs. COVID-19 from Japan:
- Kyoto University Hospital said Thursday it had performed the world’s first living-donor lung transplant on a patient who lost the functionality of both lungs due to COVID-19. After the 11-hour op, both donors — the patient’s husband and son — are stable, and the patient is expected to be discharged within two months.
- The pandemic has posed many unanticipated, complex challenges. Whether it be for formulating more efficient transport solutions for sick people and test kits, or the implementation of social distancing, several Japanese firms are leaning on Canadian quantum computing expertise in search of solutions.
- A Japanese team has found some existing medicines effective in inhibiting RNA viruses, including the new coronavirus, through an experiment using induced pluripotent stem (iPS) cells. These included drugs currently used to treat osteoporosis and diabetes, as well as remdesivir, an antiviral drug already approved in Japan as a COVID-19 treatment.
- Privately-run COVID-19 testing centers for passengers boarding at Haneda Airport in Tokyo opened Saturday, offering antigen tests, which provide results in roughly 15 minutes, for ¥1,800 ($16), and polymerase chain reaction (PCR) tests, which take longer, for ¥1,900.
- A fully automated coronavirus PCR testing system began operations at Fujita Health University in Aichi Prefecture last month. The system, housed in a container 2.5 meters wide and 12.2 meters long, has 13 robotic arms and conducts all the steps required to test samples without human intervention.